James L. Speyer
Professor Emeritus of Medicine, Department of Medicine · NYU Grossman School of Medicine
Credentials: · ·
History
Research
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
Journal of Clinical Oncology · 1997 · 496 citations
New England Journal of Medicine · 1988 · First of over 10 authors · 330 citations
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer
Journal of Clinical Oncology · 1992 · First of over 10 authors · 288 citations
- FM
33 papers
26 papers · 4 as a fellow
- JW
25 papers
- RB
18 papers
16 papers · 3 as a fellow
- SW
10 papers
9 papers
8 papers
Grants
- 1997–2024
National Cancer Institute · P30
Project lead · $321.3K · New York University School of Medicine
- 1997–2000
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $196.6K · New York University School of Medicine
- 1984–1990
Trial of Icrf-187 to Decrease Doxorubicin Cardiomyopathy
National Cancer Institute · R01
Contact PI · $455.8K · New York University